SecBot SecBot

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

S. 1717 Sen. Todd Young (R-IN) In committee
Bill text PDF
  1. Introduced May 12
  2. Committee May 12
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, May 12, 2025Next: Senate vote
533d ago May 12, 2025: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
7companies, 47 filings
Subscribe to see spend
Member trades
15trades in the last 90 days
Subscribe to see who
Who the bill helps and hurts Subscribe

Companies lobbying on this bill

7 companies
Companies by sector
Medical Devices & Healthcare 5Biotech & Pharma 1Industrials 1
Search all 7 companies, their asks and price moves Subscribe

Summary

Summary not yet published by the Library of Congress. The official title is "Ensuring Patient Access to Critical Breakthrough Products Act of 2025".

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.